We found increased expression of CD86 on tumor-associated, vaccine-derived Stat3∆/∆ CD103+ cDC1s compared to Stat3fl/fl CD103+ cDC1s, as judged by relative CD86 amounts on CD45.2+ CD103+ cDC1s (Figure 3A,B). The gene discussed is CD86; the disease is neoplasm.